| Perinatal solid tumor management | Sabine Sarnacki (France) |
| Oncolytic viruses for treatment of cancer | Marta Alonso (Spain) |
| Social functioning in pediatric brain tumor survivors: the forgotten late effect | Matthew C. Hocking (US) |
| Fostering a Culture of Patient Safety: Initiating Discussions about Traditional and Complementary Medicine with Children and Families | Mohammad R. Alqudimat (Canada) |
| Myeloproliferative syndromes | Henrik Hasle (Denmark) |
| Diagnosing solid tumors using molecular biology | Edmund Cheesman (UK) |
| IPSO: Centralization of pediatric surgical oncology care | Marc Wijnen (the Netherlands) |
| PROS: D’angio lecture | Natia Esiasivili (US) |
| Delivering palliative care in children with cancer in low and middle income countries |
| Pediatric Precision Medicine: Psychosocial, health system, and ethical considerations |
| Beyond HLH 2004 – a fresh look at HLH |
| Advances in the treatment and biology of malignant rhabdoid tumour |
| Paediatric thyroid cancers |
| Treatment abandonment |
| Rare lymphoma eg. ALCL, PMBCL etc. |
| NF2 related nervous system tumours |
| SIOP/PROS/IPSO symposium: Extremity sarcoma RT |
| PROS: Mult-Disc Session |
| Implementing quality improvement in a clinical setting | Mavis Boahemaa Obuoh-Evans (Ghana) |
| Surgical oncology in LMICs | Derek Harrison (South Africa) |
| Oral metronomic chemotherapy | Jaroslav Sterba (Czech Republic) |
| Alternative donor HSCT | Marie Bleakley (US) |
| Infant ALL | Daisuke Tomizawa (Japan) |